BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22104220)

  • 1. [Relationship between the genetic polymorphisms of phase I and II drug-metabolizing enzymes, as well as the outcome of chemotherapy in advanced non-small cell lung cancer].
    Li W; Yue W; Yang X; Zhang C; Wang Y
    Zhongguo Fei Ai Za Zhi; 2011 Nov; 14(11):858-64. PubMed ID: 22104220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients.
    Li W; Yue W; Zhang L; Zhao X; Ma L; Yang X; Zhang C; Wang Y; Gu M
    Lung; 2012 Feb; 190(1):91-8. PubMed ID: 22109568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
    Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels.
    Butkiewicz D; Cole KJ; Phillips DH; Harris CC; Chorazy M
    Eur J Cancer Prev; 1999 Aug; 8(4):315-23. PubMed ID: 10493307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of metabolic enzymes-CYP1A1, CYP2D6, GSTM1, and GSTT1, and gastric carcinoma susceptibility.
    Luo YP; Chen HC; Khan MA; Chen FZ; Wan XX; Tan B; Ou-Yang FD; Zhang DZ
    Tumour Biol; 2011 Feb; 32(1):215-22. PubMed ID: 20878561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer].
    Li WY; Lai BT; Zhan XP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1042-5. PubMed ID: 15769360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of CYP1A1, GSTM1 and GSTT1 gene polymorphisms with risk of non-small cell lung cancer in Andhra Pradesh region of South India.
    Peddireddy V; Badabagni SP; Gundimeda SD; Mamidipudi V; Penagaluru PR; Mundluru HP
    Eur J Med Res; 2016 Apr; 21():17. PubMed ID: 27090234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
    Suzuki S; Muroishi Y; Nakanishi I; Oda Y
    J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenobiotic/drug metabolizing enzyme and TP53 polymorphisms and clinical outcome in advanced nonsmall cell lung cancer patients.
    Karacaoğlan V; Ada AO; Bilgen S; Çetinkaya GT; Soydaş E; Kunak CS; Alpar SM; Gülhan M; Işcan M
    Turk J Med Sci; 2017 Apr; 47(2):554-562. PubMed ID: 28425245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people.
    Quiñones L; Lucas D; Godoy J; Cáceres D; Berthou F; Varela N; Lee K; Acevedo C; Martínez L; Aguilera AM; Gil L
    Cancer Lett; 2001 Dec; 174(1):35-44. PubMed ID: 11675150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population.
    Wang J; Deng Y; Li L; Kuriki K; Ding J; Pan X; Zhuge X; Jiang J; Luo C; Lin P; Tokudome S
    Cancer Sci; 2003 May; 94(5):448-52. PubMed ID: 12824892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 1A1, 2E1 and GSTM1 gene polymorphisms and susceptibility to colorectal cancer in the Saudi population.
    Saeed HM; Alanazi MS; Nounou HA; Salaby MA; Semlali A; Azzam N; Aljebreen A; Alharby O; Parine NR; Shaik J; Arafaha M
    Asian Pac J Cancer Prev; 2013; 14(6):3761-8. PubMed ID: 23886179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
    Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
    Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes.
    Kiss I; Sándor J; Pajkos G; Bogner B; Hegedüs G; Ember I
    Anticancer Res; 2000; 20(1B):519-22. PubMed ID: 10769717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic and phenotypic polymorphisms in carcinogen-metabolizing enzymes and cancer susceptibility].
    Watanabe M
    Nihon Rinsho; 1996 Aug; 54(8):2261-75. PubMed ID: 8810806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma.
    Kim JW; Lee CG; Park YG; Kim KS; Kim IK; Sohn YW; Min HK; Lee JM; Namkoong SE
    Cancer; 2000 May; 88(9):2082-91. PubMed ID: 10813720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north indian population.
    Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
    Mol Cell Biochem; 2004 Nov; 266(1-2):1-9. PubMed ID: 15646021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes and lung cancer risk.
    Dialyna IA; Miyakis S; Georgatou N; Spandidos DA
    Oncol Rep; 2003; 10(6):1829-35. PubMed ID: 14534704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer.
    Przygodzki RM; Bennett WP; Guinee DG; Khan MA; Freedman A; Shields PG; Travis WD; Jett JR; Tazelaar H; Pairolero P; Trastek V; Liotta LA; Harris CC; Caporaso NE
    Pharmacogenetics; 1998 Dec; 8(6):503-11. PubMed ID: 9918134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.